 |
*
Recommended in :
|
How
it works : Instead
of a conventional needle, the Injex system employs an
injection ampule
with a micro orifice of just 0.17 mm. By comparison, the
diameter
of the thinnest needle is 0.25 mm. Using high pressure
created by
a compressed spring within the Injex, the
medicine
is propelled into the subcutaneous disposed tissue
(hypodermic application).
Penetration depth is 4 to 9 mm, depending on the injected
volume of
the drug. |
|
| Application
: The
Injex has been designed for those who require subcutaneous
delivery
of medication over a longer period of time. Another
advantage of this
system is that it is extremely durable (5 years guarantee).
In the future
this system could also be used successfully in a variety of
other
areas, where medicines have to be administered
subcutaneously. Needle-free delivery also results in better patient compliance as well as insuring a high level of application safety. All the basics of this, where established with the help of a validated ex vivo model. Additionally the model permits the examination of all drugs regarding their pharmacokinetics following needle-free application. The study results showed a penetration depth between 4mm - 9mm when 0.05 to 0.5 ml of liquid dye was used. An injection into skeletal muscle was not observed in over 100 experiments. |
||
| A
contribution towards limiting costs for public and private
health
care providers : *Diabetics who move onto insulin too late cause considerable additional cost for the cost carriers. *Diagnosis and treatment cost for HIV or Hepatitis caused by needle stick accidents are reduced. *Bedtime in the hospital can be shortened. *Out-patient treatment of cancer patients and injection carried out by relatives are considerably simplified. Possible lowering of costs through the use of nursing services |
||
 Insulin
injection without a needle... <<Details |
SEE
DEMO Click Here |
 Local
Anaesthesiawithout needle... Details>> |
| INJEX Needle-free Injection System registered as Medical Aid The Central Associations of health insurance companies represented by the IKK Federal Association are responsible for the issue of the medical aid register (§128 SGB V) where refundable remedies and aids are listed. Prior to registration of medical aids these products are tested by the medical service of the central associations (MDS) regarding the functionality, therapeutic benefit and quality. |
